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SUMMARY
Exposure to the herbicide paraquat (PQ) is associ-
ated with an increased risk of idiopathic Parkinson’s
disease (PD). Therapies based on PQ’s presumed
mechanisms of action have not, however, yielded
effective disease therapies. Cellular senescence is
an anticancer mechanism that arrests proliferation
of replication-competent cells and results in a
pro-inflammatory senescence-associated secretory
phenotype (SASP) capable of damaging neighboring
tissues. Here, we demonstrate that senescent cell
markers are preferentially present within astrocytes
in PD brain tissues. Additionally, PQ was found to
induce astrocytic senescence and an SASP in vitro
and in vivo, and senescent cell depletion in the latter
protects against PQ-induced neuropathology. Our
data suggest that exposure to certain environmental
toxins promotes accumulation of senescent cells in
the aging brain, which can contribute to dopami-
nergic neurodegeneration. Therapies that target se-
nescent cells may constitute a strategy for treatment
of sporadic PD, for which environmental exposure is
a major risk factor.
INTRODUCTION
Although genetic mutations that result in the development of
familial Parkinson’s disease (PD) have been identified, these
account for a minority of disease cases. The majority of cases
are sporadic in nature and likely involve the contribution of
various environmental exposures over the course of the lifespan
(Wirdefeldt et al., 2011). A better understanding of the mecha-
nisms involved in the contribution of these factors to neuropa-
thology is a vital missing piece of the puzzle that will help unravel
the underlying causes of idiopathic disease. Exposure to the
herbicide paraquat (PQ) is strongly associated with increased
lifetime risk for the development of sporadic PD. Its systemic
administration in mice results in several hallmark neuropatholog-
ical features of the disorder. However, therapies based on the
agent’s presumed mechanisms of action have yet to yield effec-
tive disease therapies (Le et al., 2014; Wirdefeldt et al., 2011).
Preventive and therapeutic treatments for idiopathic PD may
require uncovering of disease mechanisms and targets distinct
from those identified to date.
We report the contribution of a factor thought to contribute to
aging in many tissues: cellular senescence (Campisi, 2013;
Chinta et al., 2013, 2015; Salminen et al., 2011). Cellular senes-
cence is an anticancer mechanism occurring in cells capable of
division, and it results in irreversible arrest of cell proliferation in
response to stress that puts cells at risk for malignant transfor-
mation (Campisi, 2013; Prieur and Peeper, 2008). Senescent
cells express a senescence-associated secretory phenotype
(SASP)—the robust secretion of numerous inflammatory cyto-
kines, chemokines, growth factors, and proteases (Coppe´
et al., 2008). Senescent cells accumulate with age in many
human and mouse tissues. There, presumably by virtue of the
SASP, they have been shown to contribute to the age-related
loss of tissue structure and function (Baker et al., 2016; Campisi,
2013; Dimri et al., 1995; Mun˜oz-Espı´n and Serrano, 2014; van
Deursen, 2014). Cellular senescence may be an example of
evolutionary antagonistic pleiotropy—protecting organisms
from cancer early in life but driving aging phenotypes at
advanced age.
Although senescent cells have been demonstrated to
contribute to age-related pathologies outside the brain, evi-
dence to date for their contribution to age-related neurodegener-
ative diseases is only correlative (Bhat et al., 2012; Chinta et al.,
2015; Mombach et al., 2015; Salminen et al., 2011; Turnquist
et al., 2016). Here, we report that postmortem tissue from
sporadic PD patients displays increased expression of senes-
cent markers, particularly within astrocytes. PQ is also able to
induce senescence in cultured human astrocytes and in vivo.
Significantly, inducible depletion of in vivo senescence reduces
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the development of neurodegenerative phenotypes associated
with systemic PQ exposure, demonstrating that senescent cells
contribute to neurodegeneration in an in vivo neurodegenerative
disease model. Our data suggest that strategies aimed at elimi-
nating senescent cells hold promise as potential therapies to
mitigate the development of sporadic PD, for which environ-
mental stress is a major contributing factor.
RESULTS
Senescent Astrocytes and SASP Factors Are Elevated in
Parkinsonian Substantia Nigra Pars Compacta
Astrocytes expressing senescence markers increase in human
brain tissue during normal aging (Kang et al., 2015) and further
in affected brain regions of individuals with Alzheimer’s disease
(AD) and amyotrophic lateral sclerosis (ALS) (Bhat et al., 2012;
Turnquist et al., 2016), prompting us to ask whether senescent
astrocytes are also present in PD (Figures 1A and 1B).
Compared to control tissues, Parkinsonian SNpc tissues
displayed elevated expression of the senescence marker
p16INK4a, and several SASP factors included the protease
MMP-3 and the pro-inflammatory cytokines interleukin-6
(IL-6), IL-1a, and IL-8 (Figure 1A). Elevated p16INK4a and
MMP-3 expression has also been reported in cortical tissue
from AD patients (Bhat et al., 2012).
We next determined whether SNpc astrocytes in particular
display evidence of cellular senescence in PD tissues. A reduced
nuclear level of lamin B1, detectable by immunostaining in intact
tissue, is an established senescence-associated marker (Freund
et al., 2012). Astrocytes (GFAP+ cells) were found to be lamin B1
deficient in PD SNpc tissues while no significant difference was
detected in PD versus aged-matched control tissues in non-
astrocytic (GFAP) neighboring cells (Figures 1B and S1). These
findings suggest the elevated presence of senescence in
affected PD tissues and that astrocytes may preferentially un-
dergo senescence in diseased brain tissues.
PQ Induces Senescence and an SASP in Human iPSC-
Derived Astrocytes
We next assessed the ability of human astrocytes derived from
induced pluripotent stem cells (iPSCs) to undergo senescence
in response to PQ, an environmental insult significantly associ-
ated with PD (Pezzoli and Cereda, 2013). In adult mice, chronic,
low-dose systemic exposure to PQ recapitulates several impor-
tant hallmarks of the disease, including selective loss of dopami-
nergic (DAergic) SNpc neurons and reduced motor function
(McCormack and Di Monte, 2003; Pezzoli and Cereda, 2013;
Tanner et al., 2011). Cultured human astrocytes exposed to PQ
ceased proliferation based on decreased percentage of bromo-
deoxyuridine (BrdU)-labeled cells (Figure 2A). They also dis-
played several additional hallmarks of senescence, including
increased senescence-associated b-galactosidase (SA-b-gal)
activity (Dimri et al., 1995) (Figure 2B), increased levels of
p16INK4a (Beause´jour et al., 2003) mRNA and protein (Figures
2C and 2D), and increased numbers of 53BP1 foci, the latter
indicative of DNA-damage signaling, which is a potent stimulator
of the SASP (Beause´jour et al., 2003)(Figure 2E). Consistent with
development of an SASP, PQ also induced robust secretion of
the pro-inflammatory cytokine IL-6 (Figure 2F), a prominent
component of the SASP (Coppe´ et al., 2008).
Given that genotoxic stress induced by ionizing radiation (IR)
initiates senescence with well-documented effects on mitosis
and nuclear size (Pospelova et al., 2013), we verified that
compared to IR, PQ caused a similar decrease in the percentage
of Ki67+ cells (Figure 3A) and an increase in the mean size of
astrocyte nuclei (Figure. 3B). Human fibroblasts cultured with
PQ for 24 hr also displayed these phenotypes as well as
decreased Lamin B1 levels and increased SA-b-gal activity (Fig-
ures 3A–3D). These data indicate that PQ is capable of inducing
senescence in human astrocytes as well as human fibroblasts
(Jung et al., 2009). However, astrocytes were more sensitive
than fibroblasts to PQ-induced senescence based on SA-b-gal
activity. Interestingly, a concentration of PQ that induced
Figure 1. Senescence Markers in PD SNpc
versus Age-Matched Controls
(A) RNA isolated from autopsied SNpc tissues
from PD versus controls (n = 5) were analyzed for
p16INK4a and SASP factor (IL-6, IL-1a, IL-8, and
MMP-3) mRNA levels by qPCR. Transcripts were
normalized to actin and are shown as fold change
over control levels; *p < 0.05 and ***p < 0.005.
(B) Comparison of lamin B1 levels in PD versus
age-matched control tissues. Representative
immunofluorescence images (left side) showing
lamin B1 protein levels (green) in GFAP+ (red) as-
trocytes (red arrows) in the PD SNpc (right panels)
compared to age-matched controls (left panels).
Neighboring GFAP cells (yellow arrows) retain
lamin B1 expression in PD tissue. Quantification of
the image data (right side) using mean pixel values
(MPVs) showing that compared to controls (black
bar; n = 5 individuals), PD tissues (gray bar; n = 5
individuals) contained significantly less Lamin B1
protein in GFAP+, but not GFAP, cells; *p < 0.05
(paired t test).
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Figure 2. PQ Induces Senescent Phenotypes in
Cultured Human Astrocytes
Cultured human astrocytes were treated with 100 or 250 mMPQ
(or vehicle) for 24 hr, and senescence markers were evaluated
7 days later.
(A) Representative images of BrdU labeling (left), and percent-
age of BrdU+ cells (right).
(B) Representative images of SA-b-gal activity (left), and per-
centage of SA-b-gal+ cells (right).
(C) qPCR of p16INK4a mRNA levels.
(D) Representative images of immunostaining for p16INK4a (left),
and percentage of p16INK4a-positive cells (right).
(E) Representative images of 53BP1 immunostaining (left), and
percentage of cells with >1 53BP1 positive foci (right). Nuclei
were counterstained with DAPI (blue) and white arrows denote
enlarged cells shown in insets with punctate nuclear foci.
(F) Secreted IL-6 levels measured by ELISA in conditioned
media from non-senescent (vehicle) and senescent (PQ) as-
trocytes.
For (A)–(D), n = 4, where n = experimental replicates; *p < 0.05,
**p < 0.01, and ***p < 0.005 (unpaired t test).
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Figure 3. Paraquat Induces Morphological
Features of Senescence and Arrests Prolifera-
tion in Both Fibroblasts and Astrocytes
(A) Human fibroblasts (top panels) and human astro-
cytes (bottom panels) respond to PQ (1 mM and
300 mM, respectively) by decreasing the percentage of
Ki67+ cells (green) compared to vehicle-treated con-
trols. Representative images (left) and quantification
(right) are shown. The decreased percentage of Ki67+
cells is similar to the decrease observed when cells are
exposed to 10 Gy X-ray (IR, middle panels). For fibro-
blasts, both IR and 1 mMPQ significantly reduced Ki67
positivity; ***p < 0.00001 (1 mM PQ was not signifi-
cantly different from IR [p > 0.07]; unpaired t test); n = 4
experiments. For astrocytes, IR and 300 mM PQ
significantly reduced Ki67 positivity; **p < 0.01 (300 mM
PQ was not significantly different from IR [p > 0.8];
unpaired t test); n = 2 experiments.
(B) Human fibroblasts (top) and human astrocytes
(bottom) respond to PQ with a significant increase in
nuclear size compared to vehicle-treated controls.
Representative images (left) and quantification (right)
are shown. Increased nuclear size is similar to the in-
crease obtained with IR exposure. For fibroblasts both
conditions (IR and 1mM PQ) are significantly greater
than control; ***p < 0.0001 (1 mM PQ is not significantly
different from IR [p > 0.30]; unpaired t test); n = 6 ex-
periments. For astrocytes, both conditions (IR; 300 mM
PQ) are significantly greater than control; *p < 0.02
(300 mM PQ is not significantly different from IR
[p > 0.5]; unpaired t test); n = 5 experiments.
(C) Human fibroblasts respond to PQ (500 mM and
1 mM) with a significant loss of lamin B1 staining in the
nuclear lamina relative to vehicle-treated controls.
Representative images (left) and quantification (right)
are shown. Decreased lamin B1 staining is similar to
that obtained with IR. All conditions (IR; 500 mM and
1 mM PQ) are significantly different from control;
**p < 0.01 (neither PQ condition differed significantly
from IR [p > 0.25]; unpaired t test); n = 2 experiments.
(D) Human fibroblasts (1 mM PQ, top), astrocytes
derived from iPSCs (40 mM PQ, middle), and murine
primary astrocytes from p16-3MR neonates (40 mM
PQ, bottom), display obvious increase in SA-b-gal ac-
tivity, but cell death occurred when human and mouse
astrocytes were exposed to higher concentrations of
PQ (500 and 250 mM, respectively).
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fibroblast senescence (>500 mM PQ) was lethal to astrocytes
(Figure 3D).
Epidemiological data suggest that, although the risk for devel-
oping PD is significant following a short-term (<8 day) environ-
mental exposure to PQ, PD is even more significantly linked
with chronic/low-dose PQ exposure (Tanner et al., 2011). We
asked whether lower concentrations of PQ for a longer duration
could induce senescence in human astrocytes. Cells exposed
for 48 hr to 10 mM PQ showed a significant increase in SA-
b-gal+ cells, and a 48-hr exposure to 50 mM PQ was nearly as
effective as a 24- hr exposure to 100 mM PQ (Figure 4A). All ex-
posures and concentrations reduced cell numbers compared to
vehicle-treated cells consistent with proliferative arrest (Fig-
ure 4B). Lower more sustained PQ doses increased the percent-
age of senescent astrocytes to a similar or greater extent than
exposure to H202 (150 mM for 2 hr) or the proteasomal inhibitor
MG132 (50 nM for 48 hr) (Figure 4A), which are stress conditions
reported to induce senescence of cultured human astrocytes
(Bitto et al., 2010).
Soluble Factors Secreted by Senescent Human
Astrocytes Compromise the Function of Neurons and
Neural Progenitor Cells
Senescent cells can exert powerful paracrine effects on tissue
microenvironments (Coppe´ et al., 2010); SASP factors have
been shown to disrupt tissue structure and function (Brkic
et al., 2015). We asked whether PQ-induced senescent astro-
cytes could drive PD-related neuropathologies associated with
the neurotoxin, including DAergic neuronal cell death (Blesa
and Przedborski, 2014) and reduced neural progenitor cell
(NPC) proliferation and migration (Marxreiter et al., 2013). We
cultured human DAergic neurons and NPCs in the presence of
conditioned media (CM) from human astrocytes. CM from PQ-
induced senescent astrocytes, but not non-senescent (vehicle-
treated) astrocytes, significantly reduced the viability of DAergic
neurons (Figure 5A). Similarly, CM from senescent astrocytes
suppressed both NPC proliferation (Figure 5B) and migration
(Figure 5C).
IL-6 is a prominent SASP factor, and elevated serum levels are
associated with increased PD risk (Scalzo et al., 2010). Treating
cultured DAergic neurons with recombinant IL-6 at the concen-
tration found in the CM of PQ-treated astrocytes (1.5 mM)
showed a trend toward reducing DAergic cell viability, but the ef-
fect was not statistically significant (Figure S2). This finding sug-
gests that although IL-6 may contribute to neurotoxic SASP ef-
fects, additional factors are likely needed to mediate the
detrimental impact on DAergic viability.
Depleting Senescent Cells Abrogates PQ-Induced
Neuropathology
To test whether PQ-induced senescence contributes to neuro-
pathologies in vivo, we used amousemodel that allows selective
depletion of senescent cells (Demaria et al., 2014). These mice
(p16-3MR) use the promoter for the senescence marker
p16INK4a to drive expression of a modified herpes simplex virus
thymidine kinase (HSV-TK), which converts the pro-drug ganci-
clovir (GCV) into a DNA chain terminator, causing cells to
apoptose (Laberge et al., 2013). GCV eliminates 70%–80% of
senescent cells in p16-3MR mice without discernible off-target
or bystander effects (Demaria et al., 2014).
We subjected p16-3MR mice to a systemic PQ regimen
shown to result in several neuropathological features of PD
(McCormack and Di Monte, 2003; Shimizu et al., 2001). PQ
increased nigrostriatal expression of p16INK4a and IL-6 (Fig-
ure 6A). As was the case for human astrocytes, PQ-treated
p16-3MR astrocytes display increased SA-b-gal activity and
weremore sensitive to PQ-induced toxicity. Similar to astrocytes
in human PD tissues, astrocytes from PQ-treated mice also dis-
played significant loss of nuclear lamin B1 and HMGB1 (high
mobility group box 1), the latter necessary for SASP initiation
(Figures 6B and 6C) (Davalos et al., 2013). Similar to our findings
in the human PD SNpc, PQ did not significantly reduce nuclear
lamin B1 in GFAP cells (Figure 6D). Significantly, all senescent
phenotypes in the SNpc were abrogated in mice in which senes-
cent cells were eliminated by systemic GCV administration (Fig-
ures 6A–6D). We failed to detect a decline in the proliferation
marker Ki67 in astrocytes in PQ-treated mice (Figure S3). How-
ever, Ki67 staining in astroglia in saline-treated animals was
within the range of post-mitotic neurons and less than half the
levels found in Ki67+ cells within the inner granule cell layer of
the dentate gyrus, which are presumed to be actively dividing
granule cell progenitors (Nicola et al., 2015).
Human PD neuropathology is characterized by the preferential
loss of DAergic neurons in the SNpc, resulting in impairment of
locomotor function (Jankovic, 2008). These phenotypes are
recapitulated in the systemic PQ murine model. In the mouse
Figure 4. Lower Dosages of PQ Also Induce
Cellular Senescence
(A) Images and quantification percentage of SA-
b-gal+ cells of human astrocytes exposed to 10 or
50 mM PQ for 48; also shown are results from
exposure to 150 mM H2O2 for 2 hr and 50 nM
MG132 for 48 hr; *p < 0.05, **p < 0.01, and
***p < 0.005.
(B) Images and quantification of cell density based
on DAPI staining after exposure to 10 or 50 mM PQ
for 48 hr; *p < 0.05 and **p < 0.01.
For (A) and (B), n = 4, where n = experimental
replicates (unpaired t test).
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SNpc, PQ caused a significant decline in a marker of DAergic
neurons, tyrosine hydroxylase (TH); co-administration of GCV
with PQ prevented this decline (Figure 7A). Systemic PQ admin-
istration is known to repress adult neurogenesis, but co-GCV
administration abrogated this effect (Figure 7B) (Marxreiter
et al., 2013). Finally, rearing behavior, a measure of motor neuron
function more sensitive to DAergic cell loss than other motor
tests (Willard et al., 2015), was significantly curbed in mice
treated with PQ alone but normal in mice co-treated with GCV
(Figure 7C). Taken together, these results suggest that senes-
cent cell depletion abrogates PQ-mediated neuropathology
and motor deficits.
DISCUSSION
Late-onset idiopathic PD is thought to result from the combined
effects of genetic risk factors, aging, and environmental expo-
sure. Data from several laboratories suggest that humans and
animals exposed to certain chemicals can develop neuropatho-
logical phenotypes associated with PD (Chinta et al., 2008;
McCormack et al., 2005; Peng et al., 2010). One of the best stud-
ied of these is PQ. A meta-analysis of >100 epidemiological
studies concluded that of several specific pesticides and chem-
ical classes evaluated, only PQ was significantly associated with
PD. Moreover, as this study points out, the epidemiologic data
are backed by numerous animal studies demonstrating that
PQ selectively depletes SNpc DAergic neurons and reduces
motor function in adult mice, which are important hallmarks of
human PD (Pezzoli and Cereda, 2013).
PQ is a free radical generator that causes oxidative stress (Bus
and Gibson, 1984), which has been demonstrated to induce
cellular senescence in replication-competent cell types (Campisi,
2013). PQ also results in compromised mitochondrial function,
which has recently been tied to senescence induction in human
fibroblasts (Wiley et al., 2016). One mechanism by which PQ
may contribute to PD is by inducing cellular senescence within
the brain (Chinta et al., 2013). Indeed, PQ induced senescence
more readily in cultured human and murine astrocytes than in
human fibroblasts, and their sensitivity was found to track with
baseline SA-b-gal activity. Our studies suggest that PQ, like other
inducers of senescence (Park et al., 2013), has a bandwidth of
concentrations that induce senescence; above an upper limit,
cells die. This finding raises the possibility that astrocytes are
particularly prone to undergo senescence in response to chronic
low-dose exposure to PQ that is associated with late-onset
idiopathic PD. Indeed, administration of PQ to mice appears to
preferentially increase senescent markers in astrocytes. Impor-
tantly, senescence markers were also elevated in astrocytes in
SNpc tissues from autopsied PD brain samples, suggesting
that the proclivity for astrocytes to undergo senescence may
have physiological disease relevance. To our knowledge, this is
the first report of elevated senescent markers in the PD brain.
While our data suggest that senescence occurs preferentially
within astrocytes, this does not rule out senescence induction of
other brain cell types. While neurons are post-mitotic and there-
fore unlikely to undergo traditional senescence induction, senes-
cence has reported in other non-astrocytic cell types. For
example, in response to repeated lipopolysaccharide adminis-
tration, microglial BV2 cells display growth arrest, enhanced
SA-b-gal activity, and heterochromatic foci (Yum et al., 2012).
Based on our own findings that PQ can mediate senescence in
disparate cell types (astrocytes and fibroblasts), we anticipate
that at some concentrations PQmay induce senescence of other
replicative brain cell types.
It is theoretically possible that senescence induction in periph-
eral tissues could contribute to PQ-mediated brain pathologies,
but this seems unlikely, as the chronic, low-dose PQ regimen
utilized in our studies is known to result in receptor-mediated
uptake and immune response in the brain (McCormack and Di
Monte, 2003) without activating peripheral immune cells or
disrupting blood-brain barrier integrity (Vilas-Boas et al., 2014;
Watson et al., 2013).
How might senescent astrocytes contribute to PD neuropa-
thology? Mature astrocytes rarely divide in the adult brain (Ge
Figure 5. Factors Secreted by Senescent
HumanAstrocytesHaveDetrimental Effects
(A) Conditioned media (CM) from PQ-treated
human astrocytes was added to DAergic neurons,
and cell viability was assessed via an MTT assay;
n = 3 experiments.
(B) CM from PQ-treated human astrocytes was
added to neural progenitor cells (NPCs), and
proliferation of NPCs was assessed by BrdU
positivity. Representative images (left) and quan-
tification (right) are shown; n = 3 experiments.
(C) NPCs migration in the presence of CM from
vehicle-treated (black bars) versus PQ-treated
(250 mM) (gray bars) astrocytes assayed using the
scratch test; images show ‘‘cleared areas’’ of NPCs
at 0 hr (far left panels), 24 hr (middle panels), and
48 hr (right panels) post-scratch. Black lines
(perpendicular to scratches) indicate the width of
the uninvaded area used for the quantification (right
side). The percent scratch width >24 and 48 hr was
calculated;n=5scratches. Theexperimentwas run
twice with 2 different sets of CM (2 scratch assays).
*p < 0.05 (unpaired t test).
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et al., 2012; Sohn et al., 2015), consistent with our inability to
detect Ki67+ astrocytes in the adult mouse brain; however, as-
trocytes do divide in response to certain injury (Barreto et al.,
2011) and disease states (Boekhoorn et al., 2006; Bondolfi
et al., 2002). The inability of senescent astrocytes to proliferate
may exacerbate neuropathology when proliferation is an appro-
priate response to injury or disease. Astrocytes provide struc-
tural, metabolic, and trophic support to neurons (Allaman et al.,
2011). When astrocytes adopt pro-inflammatory phenotypes,
they can compromise neuronal function and contribute to age-
related neurodegeneration and decrements in brain function
in vivo (Rossi, 2015; Salminen et al., 2011). Factors secreted
by senescent astrocytes had detrimental effects on both
cultured human DAergic neurons and NPCs. CM from senescent
astrocytes was supplemented with growth factors; therefore,
trophic factor depletion seems an unlikely explanation. Secretion
of IL-6 by cultured senescent human astrocytes was recently re-
ported to decrease the viability of co-cultured motor neurons
(Turnquist et al., 2016). We observed a similar increase in IL-6
secretion following PQ treatment in culture or in vivo, but IL-6
alone was not sufficient to induce significant degeneration of
cultured DAergic neurons, suggesting that additional SASP
factors may be required.
Why do DAergic SNpc neurons selectively degenerate in
response to PQ and in PD? This is a pressing question in the field
that our study does not explicitly address. However, we hypothe-
size that DAergic SNpc neurons may be particularly sensitive to
theeffectsofoxidative stressonneighboringastrocytes, including
senescence induction. In agreement with this idea, using an
inducible astrocyte-specific oxidative stress mouse model, we
previously demonstrated selective degeneration of DAergic
SNpc neurons, despite astrocytes in other brain regions experi-
encing similar levels of oxidative stress (Mallajosyula et al., 2008).
In conclusion, our data show that astrocytes undergo cellular
senescence in response to a well-established environmental
stressor linked to PD and, significantly, that PQ-induced senes-
cence contributes to PD-related neuropathology. This finding
provide novel links among environmental exposure, cellular
senescence, and PD. Further studies are warranted to identify
other environmental and endogenous stressors capable of
senescence induction in the brain. Our results suggest that se-
nescent cells might be a novel therapeutic target for sporadic
PD and other chronic neurodegenerative diseases in which envi-
ronmental factors are implicated.
EXPERIMENTAL PROCEDURES
PD Tissues and Ethics Statement
Formalin-fixed paraffin-embedded SNpc sections were obtained from the
Neurodegenerative Disease Research Brain Bank, University of Pennsylvania
(U Penn) Center for Neurodegenerative Disease Research. Samples were from
subjects aged 50–92 years at autopsy with previously diagnosed PD. Control
samples were from age- and sex-matched subjects without PD. All samples
were de-identified and obtained after approval by the U Penn institutional re-
view board (protocol number 180600). A broker de-identified each specimen,
no protected health information was made available to the researcher, and
specimens were assigned numbers that could not be traced to the donors.
There is no link between donor identifiers and the data; therefore, consent
for this protocol was waived.
Figure 6. PQ-Induced Senescence Is Prevented by Senescent Cell
Ablation
p16-3MRmice were treated with (1) saline, (2) PQ, (3) GCV alone, or (4) PQ plus
GCV and assessed for senescence-associated markers.
(A) Striatal RNA analyzed by qPCR for p16INK4a and IL-6 mRNA levels.
(B) SNpc immunofluorescence of Lamin B1 (green) of DAPI-stained nuclei
(blue) within a field of TH+ (magenta)-stained neurites. GFAP+ (red) astro-
cytes are indicated by yellow arrows. A representative image from each of
the 4 conditions (left) and corresponding quantification of nuclear Lamin B1
fluorescence (right). Top left inlays show lamin B1 staining within astro-
cytes.
(C) HMGB1 immunofluorescence (green) counterstained as in (B); shown are
representative images (left) and quantification of nuclear HMGB1 fluorescence
(right).
(D) Representative images (left) of lamin B1 immunofluorescence (green) in
astrocytes versus non-astrocytic neighbors and quantification (right). Neigh-
boring GFAP cells marked with yellow arrows.
In all experiments, n = 4mice for saline, PQ plus GCV, andGCV; and n = 3mice
for PQ. *p < 0.05 (unpaired t test).
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qPCR of Human Tissues and Cells
Total RNA was prepared from human SNpc or human-iPSC-derived cells us-
ing TRIzol (Invitrogen) and reverse transcribed using an Applied Biosystems kit
(Carlsbad, CA). qRT-PCR was performed using the Universal Probe Library
system (Roche, South San Francisco, CA) with the following primers and
probes:
p16INK4a: forward (FW) 50-gagcagcatggagccttc-30; RV 50-cgtaactattcggtg
cgttg-30
IL-6: FW 50-gcccagctatgaactccttct-30; RV 50-gaaggcagcaggcaacac-30
IL-1a: FW 50-ggttgagtttaagccaatcca-30; RV 50-tgctgacctaggcttgatga-30
IL-8: FW 50-agacagcagagcacacaagc-30; RV 50-atggttccttccggtggt-30
MMP-3: FW 50-caaaacatatttctttgtagaggacaa-30;RV 50-ttcagctatttgcttgg
gaaa-30.
Immunofluorescence of Human SNpc Tissue
SNpc sections (6 mM) were rehydrated as follows: 2 3 7 min, xylene; 4 min
each; 100%, 95%, 80%, and 70% ETOH; rinsed in dH20; and washed in
Tris-buffered saline (TBS), 10 min. Slides were then microwaved in 10 mM
citrate buffer (pH 6.0) for 5 min at 40% power, cooled for 20 min, washed
10 min in TBS, and then blocked with 10% normal goat serum (NGS) in
TBS + 0.05% Triton X-100 for 1 hr at room temperature. Sections were incu-
bated at 4C overnight with primary antibodies in blocking buffer (chicken
TH: Novus, NB100-1613, 1:200 dilution; lamin B1: Abcam, ab16048, 1:200
dilution). Slides were washed three times in TBS followed by TBS, 0.025%
Tween-20, 5% normal goat serum, and fluorescent conjugated antibodies
(goat anti-rabbit-488: Life Technologies, A31566, 1:500 dilution; goat-anti
chicken 633: Life Technologies, A21103, 1:500 dilution; and GFAP-cy3:
Sigma, C9205, 1:2,000 dilution). Slides were washed three times in TBS and
mounted with ProLong Gold plus DAPI (Life Technologies, P36934).
Lamin B1 Quantitation in Human SNpc Astrocytes
Immunostained sections were imaged with a Zeiss LSM 780 using an EC Plan-
Neofluar 403/1.30 oil Ph3 objective. 103 bright-field microscopy was used to
locate GFAP+ cells in the vicinity of clustered pigmented neurons. A z stack
spanning the cell body was acquired at 1,024 3 1,024 12 bit at 33 zoom
using 1-mm steps. Fluorescence intensity was assessed using ImageJ. The
optical section with the greatest green intensity (lamin B1) was identified. In
the DAPI channel, the edge of the DAPI signal was outlined (defining the
nuclear lamina), and the mean pixel value (MPV) on the green channel (lamin
B1) was calculated; this signal was divided by a signal outside all nuclei in
order to normalize for background staining and normalized fluorescence inten-
sity averaged across 5 GFAP+ cells within a single section. Neighboring
GFAP cells were chosen based on being closest and in the same Z section
as the analyzed astrocyte. Significance was calculated using a paired t test
pairing age- and sex-matched individuals from PD and control groups (n = 5
PD samples, 5 controls).
Treatment of Human Cultures
Human astrocytes derived from iPSCs purchased from XCell Science (Novato
CA) grown in astrocyte media were cultured at 37C, 3% O2, and 5% CO2 in
DMEM supplemented with 10% horse serum, 10% fetal bovine serum
(FBS), and penicillin/streptomycin. Cells were seeded at 1 3 104 cells/cm2
and cultured to 70%–80% confluence. WI-38 primary human fibroblasts
were obtained from the Coriell Cell Repository. Cell culture and irradiation
(IR, 10 Gy X-rays) were carried out as described previously (Freund et al.,
2012). Cells were treated with indicated PQ concentrations for 24 or 48 hr
andwashed twice with culturemedia; analyseswere performed 7–8 days later.
BrdU Incorporation
Cell proliferation was determined by measuring DNA synthesis using a modi-
fied BrdU labeling kit (Roche). Cells were seeded in 4-well chamber slides and
incubated with BrdU for 1 hr before washing and fixing with 4% paraformalde-
hyde. Fixed cells were washed with PBS and BrdU immunofluorescence
quantified.
SA-b-gal Assay
SA-b-gal staining was performed as described previously (Dimri et al., 1995).
Cells were plated at 1 3 104 cells/cm2 and assessed for SA-b-gal activity
24–48 hr after seeding in a minimum of 400 cells. Positive (blue) cells are
expressed as a percentage of total cell number.
Immunofluorescence of Cultured Cells
Cells were fixed with 4% formaldehyde, permeabilized with 0.5% Triton, and
blocked with 10% goat or donkey serum before incubating overnight with
primary antibody at 4C. After washing in PBS, cells were incubated with
Figure 7. Depletion of Senescent Cells Abro-
gates PQ-Mediated Neuropathological Phe-
notypes
(A) Stereological SN TH+ cell counts were per-
formed on p16-3MR mice treated with (1) saline, (2)
PQ, (3) GCV alone, or (4) PQ plus GCV. Represen-
tative images (left) and quantification (right) are
shown. Data are expressed as total SN TH+ cell
numbers per animal; cell counts were verified by
Nissl staining (not shown).
(B) Neurogenesis assessed by quantitation of
BrdU+ cells in the subventricular zone (SVZ) (Peng
et al., 2008). Representative sections showing
BrdU+ cells in the SVZ (left); quantitation of BrdU+
cells in the SVZ (right). Values are reported as BrdU+
cells per field averaged from 5 fields.
(C) Prior to sacrifice, locomotor activity was moni-
tored using the cylinder test as a measurement of
spontaneous rearing rate. Still images demon-
strating the behavioral phenotype (left) and quanti-
fication (right) are shown.
For all experiments, n = 6 per condition; *p < 0.05
(unpaired t test).
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Alexa-conjugated secondary antibodies for 30–45 min at room temperature.
Nuclear DNA was stained with DAPI in mounting media (Vectashield).
CellProfiler image analysis software was used to score cells. Primary
antibodies were anti-p16 (clone JC8: Santa Cruz Biotechnology, sc-56330,
1:200 dilution), anti-53BP1 (clone BP13: EMD Millipore, MAB3802, 1:200
dilution), anti-lamin B1 (Abcam, ab16048, 1:200 dilution), and anti-Ki67
(Abcam, ab15580; 1:200 dilution). For the latter, image data were analyzed
using CellProfiler to quantify the number of Ki67+ (% Ki67+) DAPI-stained
nuclei. The mean pixel area of DAPI-stained nuclei was obtained for each con-
dition (IR and PQ) and normalized to themean pixel area of nuclei under control
conditions (for relative nuclear size).
IL-6 ELISA
CM was prepared by washing cells three times in PBS followed by incubation
in serum-free DMEM for 24 hr. CM was filtered and stored at 80C. Cell
numbers were determined by counting. ELISAs were performed using the
alphaLISA IL-6 Immunoassay Research kit (Perkin Elmer). Data were normal-
ized to cell number and expressed as picograms per 1,000 cells.
Preparation of Primary 3MR Astrocytes
Primary cortical astrocytes were prepared as described previously (Schildge
et al., 2013). Cortices were dissected from post-natal day 2 mice and dissoci-
ated, plated, and cultured for 2 weeks with removal of microglia by orbital
shaking prior to conducting experiments. Cells were treated with PQ as indi-
cated and after 24 hr washed twice with culture media. SA-b-gal activity
was assessed 8 days after PQ treatment as described above.
Viability of Human DAergic Neurons
Primary human DAergic neurons were obtained from Celprogen (San Pedro,
CA) and cultured as instructed by the manufacturer. Cells were maintained
in complete medium and subcultured every 24–48 hr on human dopamine
neuronal primary cell culture extracellular matrix. Briefly, 1 3 104 cells were
plated onto flat-bottomed 96-well plates. CM from astrocytes was concen-
trated using spin columns with a 10-kDa cutoff and reconstituted in DA-com-
plete media. After 24 hr, cells were exposed to CM astrocytic CM for 72 hr.
Cells were treated with 50 mL MTT (3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyl-
tertra-zolium bromide) solution (5 mg/mL) for 3 hr at 37C. 200 mL dimethyl
sulfoxide (Sigma, USA) was added to each well and incubated for 30 min at
37C. Color intensity was quantified at 570 nm. The experiment was run three
times in 3 different sets of CM, and each condition was run in quadruplicate.
Derivation of Human NPCs
Human embryonic stem cell colonies were harvested after collagenase treat-
ment, cultured as embryoid bodies for 8 days in DMEM with 20% FBS, and
cultured in neural induction medium (DMEM/F12) N2 supplement (Invitrogen,
25 ng/mL basic fibroblast growth factor [bFGF]) for 7 days on plates coated
with Geltrex. Rosettes were manually isolated, dissociated into single cells
and expanded in neural expansion medium. NPCs were then incubated for
48 hr in astrocytic CM. Cell proliferation was determined a using a modified
BrdU labeling kit (Roche) as above.
Scratch Migration Assay
As described elsewhere (Liang et al., 2007), NPCs were cultured to confluence
in 60-mm dishes. The monolayer was scraped with a p200 pipet tip to create a
‘‘scratch.’’ Debris was removed and astrocytic CM was added for 48 hr. Using
phase contrast microscopy, images were acquired at 0, 24, and 48 hr after the
scratch. The mean width of each scratch was calculated by averaging 6 width
measurements taken at even intervals along the scratch length. The relative
rate of migration was determined by calculating the percentage of scratch
width invaded = 100%  (100% (mean width at tx  mean width at t0).
Quantification was carried out using ImageJ.
PQ Administration
p16-3MRmice were generated in the C57Bl6/Jmouse strain as described pre-
viously (Demaria et al., 2014). Animals were housed according to standard
animal care protocols on a 12-hr light/dark cycle in a pathogen-free environ-
ment in the vivarium at the Buck Institute. 8-month-old male and female
mice were injected intraperitoneally (i.p.) with saline or 7 mg/kg PQ (in saline)
at 2-day intervals for a total of 6 doses. GCV (25 mg/kg body weight) was
injected i.p. after the second PQ injection and every other day for a total of 5
doses. Animals were sacrificed 7 d after the last PQ administration as
described previously (Peng et al., 2010). Animal care and use were in accor-
dance with the National Institutes of Health guidelines for use of live animals
and approved by the Animal Care and Use Committee at the Buck Institute.
qPCR of Mouse Striatal Tissues
RNA from PQ- and saline-treated mice was reverse transcribed using an
Applied Biosystems kit (Carlsbad CA). qRT-PCR reactions were performed
using the following primers and probes:
p16INK4a: FW, 50-aatctccgcgaggaaagc-30, RV, 50-gtctgcagcggactccat-30
mRFP: FW, 50–gacctcggcgtcgtagtg-30, RV 50–aagggcgagatcaagatgag-30
IL-6: FW, 50- gctaccaaactggatataatcagga-30, RV, 50- ccaggtagctatggtac
tccagaa-30
tubulin: FW, 50- ctggaacccacggtcatc-30 and RV, 50- gtggccacgagcatagtt
att-30.
Immunofluorescence of Mouse Brain Tissue
Whole brains were dissected and placed in cold 4% paraformaldehyde in PBS
for 12 hr, washed in cold TBS, cut using a Leica VT 1000S Vibratome (collect-
ing 50-mm horizontal sections in cryogenic buffer [0.1 M potassium acetate,
40% ethylene glycol, and 1% polyvinyl pyrrolidone]), and stored at 20C.
Free-floating sections containing the SN were transferred to 1 mL unmasking
buffer (10 mM Tris and 1 mM EDTA [pH 9]) in 24-well dishes and microwaved
3 3 5 s at 100% power. Sections were washed in TBS, permeabilized in TBS
plus 0.2% Triton X-100 for 1 hr, blocked in 5% normal goat serum in permea-
bilization buffer for 1 hr, and then bathed in blocking buffer at 4C overnight
with primary antibodies (chicken anti-TH with either rabbit anti-lamin B1 or
rabbit anti-HMGB1, Abcam, ab18256, 1:200). Section were washed three
times with TBS plus 0.1% Tween-20 for 1 hr and bathed in TBS, 0.1%
Tween-20, 5% NGS, and fluorescent-conjugated antibodies (goat anti-rabbit
immunoglobulin G [IgG]-Alexa 488 at 1:500; goat anti-chicken IgG/Alexa 633
at 1:500, and GFAP-cy3 at 1:2,000). Primary and secondary antibodies are
the same as those listed for human IF. Sections were washed three times
with TBS plus 0.1% Tween-20 for 2 hr before mounting on glass slides with
ProLong Gold plus DAPI.
Analysis of Lamin B1 and HMGB1 in Mouse SNpc Astrocytes
Image acquisition and analysis of Lamin B1 and HMGB1 immunostaining in
mouse astrocytes was conducted similar to that described for human brain
tissues, except GFAP+ cells were chosen in fields containing TH staining.
For HMGB1 analysis, the region of interest was drawn in the center of DAPI
signal (in the nucleoplasm). Signals were calculated by averaging fluorescence
from 5 astrocytes per section and subsequently averaging 3 sections per
animal. Significance was calculated using non-paired t test with n = 4 animals
in each condition.
Stereological SN TH+ Counts
Mouse tissues were fixed by perfusion as described and cryostat-cut sections
(40 mm) were taken through the entire midbrain (Mallajosyula et al., 2008). TH+
neurons were immune-labeled by incubating the sections successively with a
rabbit polyclonal anti-TH antibody (1:200) and biotinylated horse anti-rabbit
IgG (1:200, Vector Laboratories) in combination with 3,30-diaminobenzidine
(DAB) reagents. Total # TH+ SNpc neurons were counted from 4 to 5 litter-
mates per group using the optical fractionator method (Peng et al., 2010).
Cylinder Test of Motor Behavior
Mice were placed individually in a cylinder to determine the number of rearing
events over 1 min (Willard et al., 2015). Each rearing session was video
recorded. The average number of rears over two trials was taken.
In Vivo BrdU Labeling and Quantitation
BrdU (50 mg/kg; Sigma) in saline was given i.p. two times daily at 8-hr intervals
on consecutive days (days 1–3 after PQ or saline administration). Mice were
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sacrificed on day 14 after the last injection. Brains were removed following 4%
paraformaldehyde in PBS. Adjacent 50-mm sections were cut and stored
at 80C. BrdU detection was performed as described previously (Peng
et al., 2008). Briefly, sections were incubated with 2 mg/mLmouse monoclonal
anti-BrdU antibody (1:200, Roche) at 4C overnight, washed with PBS, incu-
bated with Alexa 488 anti-mouse secondary antibody (1:250) in blocking solu-
tion (Life Technologies) for 1 hr, and then washed and mounted on gelatin-
coated slides with Fluoromount. SVZ BrdU+ cells were counted blinded in
five 50-mmcoronal sections permouse spaced 200 mmapart under high power
(2003) using aNikon E300microscopewith aMagnifire digital camera. Results
are expressed as the average number of BrdU+ cells per section.
Statistical Methods
For experiments using post-mortem human tissues (Figure 1), n represents
individuals; for all experiments using cultured cells (Figures 2, 3, 4, and 5),
n represents experimental replicates conducted on separate days; and for
all mouse studies (Figures 6 and 7), n represents individual mice. See figure
legends for exact numbers for each individual experiment. All error bars in
figures display SEM. Results were reported as significant when p values
were <0.05, running an unpaired Student’s t test, unless noted otherwise
in figure legends.
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